National Cancer Institute; Notice of Closed Meeting, 29088 [2017-13358]
Download as PDF
29088
Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK30JT082PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
TIME AND DATE: 8:30 a.m.–3:30 p.m.,
EDT, August 11, 2017.
PLACE: CDC, Building 19, Rooms 245–
246, 1600 Clifton Road, NE., Atlanta,
Georgia 30329. This meeting will also be
held by teleconference.
STATUS: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 20
people. The public is welcome to
participate during the public comment,
which is tentatively scheduled from
2:45 p.m. to 2:55 p.m., EDT. To
participate on the teleconference, please
dial 866–917–2712 and enter code
9418625.
PURPOSE: The Subcommittee will
provide advice to the ACD on strategies,
future needs, and challenges faced by
State, Tribal, Local and Territorial
health agencies, and will provide
guidance on opportunities for CDC
through the ACD.
MATTERS FOR DISCUSSION: The STLT
Subcommittee members will discuss
progress on implementation of ACDadopted recommendations related to the
health department of the future, other
emerging challenges and how CDC can
best support STLT health departments
in the transforming health system.
The agenda is subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
´
Jose Montero, MD, Designated Federal
Officer, STLT Subcommittee, ACD,
CDC, 4770 Buford Highway, MS E70,
Atlanta, GA 30341, Telephone (404)
498–0259, email: OSTLTSDirector@
cdc.gov. Please submit comments to
OSTLTSDirector@cdc.gov no later than
August 4, 2017.
Jkt 241001
National Institutes of Health
[FR Doc. 2017–13339 Filed 6–26–17; 8:45 am]
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—State, Tribal, Local and
Territorial (STLT) Subcommittee
18:33 Jun 26, 2017
[FR Doc. 2017–13358 Filed 6–26–17; 8:45 am]
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–13414 Filed 6–26–17; 8:45 am]
VerDate Sep<11>2014
Dated: June 21, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Biomarkers and Bio Specimens.
Date: July 27, 2017.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W264, Bethesda, MD 20892–9750
(Telephone Conference Call).
Contact Person: Reed A. Graves, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W264, Bethesda, MD 20892–
9750 240–276–6384, gravesr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; ‘‘Relationship
between Delirium and Alzheimer’s disease’’.
Date: July 21, 2017.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 2C223, 7201 Wisconsin
Ave., Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Isis S. Mikhail, MD, MPH,
DRPH, National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20892, 301–402–7704,
Mikhaili@Mail.NIH.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: June 21, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–13360 Filed 6–26–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Disease; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\27JNN1.SGM
27JNN1
Agencies
[Federal Register Volume 82, Number 122 (Tuesday, June 27, 2017)]
[Notices]
[Page 29088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13358]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Biomarkers and Bio Specimens.
Date: July 27, 2017.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W264, Bethesda, MD 20892-9750 (Telephone
Conference Call).
Contact Person: Reed A. Graves, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Bethesda, MD 20892-9750 240-276-6384,
gravesr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: June 21, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-13358 Filed 6-26-17; 8:45 am]
BILLING CODE 4140-01-P